Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
889.9500 -8.40 (-0.94%)
NSE Oct 17, 2025 15:31 PM
Volume: 155.5K
 

889.95
-0.94%
ICICI Securities Limited
Suven is currently on a three pronged investment plan, 1) Relocating R&D centre, 2) Replacement and upgradation of blocks at Suryapet facility and 3) Additional new block in line with FDA regulations at Pashamylaram facility...
Promoters have decreased holdings from 66.41% to 57.49% in Sep 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended